Obvio Laboratories SRL
Obvio Laboratories reported total assets of 141,001 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Oct 2025).
The score of Obvio Laboratories shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -96 % Total assets +102 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Obvio Laboratories's annual accounts
Filed annual accounts
- Year ended 31 Mar 2025filed on 31 Oct 2025
- Year ended 31 Mar 2024filed on 30 Oct 2024
- Year ended 31 Mar 2023filed on 30 Nov 2023
- Year ended 31 Mar 2022filed on 28 Nov 2022
Obvio Laboratories's financial analysis
- Solvency1.8%sector median: 48.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Obvio Laboratories
Obvio Laboratories's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0763.445.923
- VAT number
- BE0763445923
- Peppol
- Registered · 0208:0763445923 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Feb 2021
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 31 Oct 2025
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Obvio Laboratories (SRL) has been based in Uccle since 2021, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net loss of 33,304 € and equity of 2,560 €; its revenue is not published. Its solvency stands at 1.8%, below the median of its sector (48.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Obvio Laboratories
Companies in the same business, of comparable size and area, outside its group.
- Synthesites Research and experimental development on natural sciences and engineering Uccle · balance sheet 128,948 €
- Spray Ventures Research and experimental development on natural sciences and engineering Deinze · balance sheet 27,331 €
- Roger Research and experimental development on natural sciences and engineering Lasne · balance sheet 151,258 €
- BVU Consulting Research and experimental development on natural sciences and engineering Grimbergen · balance sheet 378,924 €
- Neoenea Business and other management consultancy activities Brussels · balance sheet 108,264 €
- AgroPELLETS Research and experimental development on natural sciences and engineering Péruwelz · balance sheet 441,991 €
- Koen Segers Activities of holding companies Dilbeek · balance sheet 201,013 €
- Gate2 Manufacture of other plastic products Mons · balance sheet 282,483 €
Frequently asked questions about Obvio Laboratories
What is the revenue of Obvio Laboratories?
Obvio Laboratories files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Obvio Laboratories?
In Belgium, the VAT number is the company number prefixed with BE: BE0763445923 for Obvio Laboratories, if the company is VAT-registered. Its company number (CBE) is 0763.445.923.
Where is the registered office of Obvio Laboratories?
According to the CBE register, the registered office of Obvio Laboratories is in 1180 Uccle.
What is the equity of Obvio Laboratories?
At the close of the 2025 financial year, the equity of Obvio Laboratories amounts to 2,560 €, a solvency of 1.8% of total assets.
Who manages Obvio Laboratories?
The register lists 2 active mandates at Obvio Laboratories. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Obvio Laboratories
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →